Difference between revisions of "Doxifluridine (Didox)"
Jump to navigation
Jump to search
m |
m |
||
| Line 3: | Line 3: | ||
Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase. | Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase. | ||
| − | ==Disease for which it | + | ==Disease for which it was used== |
*[[Gastric cancer]] | *[[Gastric cancer]] | ||
| Line 14: | Line 14: | ||
[[Category:Fluoropyrimidines]] | [[Category:Fluoropyrimidines]] | ||
| − | [[Category:Gastric cancer medications]] | + | [[Category:Gastric cancer medications (historic)]] |
[[Category:Stub]] | [[Category:Stub]] | ||
Latest revision as of 12:07, 27 April 2022
Not FDA approved but used in other countries.
General information
Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase.
Disease for which it was used
Also known as
- Brand name: Didox